Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Galectin Therapeutics Inc publishes a filing, an earnings call transcript or a press release.

Get GALT alerts

About Joel Lewis

Joel Lewis is recorded as Board Member at Galectin Therapeutics Inc (GALT) since January 1, 2017 and CEO at Galectin Therapeutics Inc (GALT). The newest filing on record that lists Joel Lewis as CEO and Board Member at Galectin Therapeutics Inc (GALT) is dated October 13, 2026. The proxy statement of Galectin Therapeutics Inc reports total compensation of $1,174,782 for Joel Lewis in fiscal 2025, including a base salary of $624,000. Disclosed compensation is on record for 6 fiscal years. Joel Lewis has spoken on 1 investor event across 1 company, most recently for Galectin Therapeutics Inc on September 14, 2026. Galectin Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Galectin Therapeutics Inc includes Jack W. Callicutt (CFO), Benjamin S. Carson (Board Member), Dr. Henry Brem (Board Member) and 7 others.

Joel Lewis on recent calls

“On behalf of Galactin Therapeutics, I'm pleased to provide an update on our clinical development program and share an update on our path forward as we are preparing for our phase three registration trial.”
CEO, H.C. Wainwright 28th Annual Global Investment Conference ·

Affiliation history

Company network

Leadership on record at Galectin Therapeutics Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Galectin Therapeutics Inc (GALT) $624,000 $1,174,782
2024 Galectin Therapeutics Inc (GALT) $620,167 $1,189,674
2023 Galectin Therapeutics Inc (GALT) $573,583 $963,647
2022 Galectin Therapeutics Inc (GALT) $522,917 $974,181
2021 Galectin Therapeutics Inc (GALT) $500,000 $1,167,621
2020 Galectin Therapeutics Inc (GALT) $164,773 $753,558

Recent activity